199 related articles for article (PubMed ID: 23742991)
1. An electrochemiluminescence assay for analysis of rabies virus glycoprotein content in rabies vaccines.
Smith TG; Ellison JA; Ma X; Kuzmina N; Carson WC; Rupprecht CE
Vaccine; 2013 Jul; 31(33):3333-8. PubMed ID: 23742991
[TBL] [Abstract][Full Text] [Related]
2. In Vitro ELISA Test to Evaluate Rabies Vaccine Potency.
Jallet C; Tordo N
J Vis Exp; 2020 May; (159):. PubMed ID: 32449742
[TBL] [Abstract][Full Text] [Related]
3. A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice.
Koraka P; Bosch BJ; Cox M; Chubet R; Amerongen Gv; Lövgren-Bengtsson K; Martina BE; Roose J; Rottier PJ; Osterhaus AD
Vaccine; 2014 Aug; 32(36):4644-50. PubMed ID: 24962755
[TBL] [Abstract][Full Text] [Related]
4. Development and evaluation of an anti-rabies virus phosphoprotein-specific monoclonal antibody for detection of rabies neutralizing antibodies using RFFIT.
Um J; Chun BC; Lee YS; Hwang KJ; Yang DK; Park JS; Kim SY
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006084. PubMed ID: 29267277
[TBL] [Abstract][Full Text] [Related]
5. Verification of the rabies virus glycoprotein lower limit of immunogenicity by serological assay.
Moreira WC; Machado NS; Freitas JFS; Almeida AECC; Moura WC
J Virol Methods; 2019 Feb; 264():31-37. PubMed ID: 30448319
[TBL] [Abstract][Full Text] [Related]
6. Development of competitive inhibition ELISA as an effective potency test to analyze human rabies vaccines and assessment of the antigenic epitope of rabies glycoprotein.
Soni D; Sahoo I; Mallya AD; Kamthe P; Sahai A; Goel SK; Kulkarni PS; Dhere RM
J Immunol Methods; 2021 May; 492():112939. PubMed ID: 33309752
[TBL] [Abstract][Full Text] [Related]
7. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture.
Nagarajan T; Reddy GS; Mohana Subramanian B; Rajalakshmi S; Thiagarajan D; Tordo N; Jallet C; Srinivasan VA
Biologicals; 2006 Mar; 34(1):21-7. PubMed ID: 16188454
[TBL] [Abstract][Full Text] [Related]
8. Rhabdovirus-based vaccine platforms against henipaviruses.
Kurup D; Wirblich C; Feldmann H; Marzi A; Schnell MJ
J Virol; 2015 Jan; 89(1):144-54. PubMed ID: 25320306
[TBL] [Abstract][Full Text] [Related]
9. Biophysical virus particle specific characterization to sharpen the definition of virus stability.
Clénet D; Vinit T; Soulet D; Maillet C; Guinet-Morlot F; Saulnier A
Eur J Pharm Biopharm; 2018 Nov; 132():62-69. PubMed ID: 30118752
[TBL] [Abstract][Full Text] [Related]
10. Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model.
Zhang C; Tian Y; Chen C; Wang Z; Pei J; Lin C; Zhou M; Fu ZF; Zhao L
J Virol; 2021 Sep; 95(20):e0079021. PubMed ID: 34346765
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice.
Park JE; Shin HJ
Vet Q; 2021 Dec; 41(1):202-209. PubMed ID: 33985418
[TBL] [Abstract][Full Text] [Related]
12. Chimeric rabies virus-like particles containing membrane-anchored GM-CSF enhances the immune response against rabies virus.
Kang H; Qi Y; Wang H; Zheng X; Gao Y; Li N; Yang S; Xia X
Viruses; 2015 Mar; 7(3):1134-52. PubMed ID: 25768031
[TBL] [Abstract][Full Text] [Related]
13. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice.
Ramya R; Mohana Subramanian B; Sivakumar V; Senthilkumar RL; Sambasiva Rao KR; Srinivasan VA
Clin Vaccine Immunol; 2011 Oct; 18(10):1673-9. PubMed ID: 21813661
[TBL] [Abstract][Full Text] [Related]
14. A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses.
Yu PC; Dan M; He Y; Meng SL; Yang HY; Su X; Wang YJ; Lv L; Sun YF; Tao XY; Liu Q; Liu SQ; Bi SL; Zhu WY
Microb Pathog; 2023 Dec; 185():106425. PubMed ID: 37923181
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG
Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730
[TBL] [Abstract][Full Text] [Related]
16. A new recombinant rabies virus expressing a green fluorescent protein: A novel and fast approach to quantify virus neutralizing antibodies.
Qin S; Volokhov D; Rodionova E; Wirblich C; Schnell MJ; Chizhikov V; Dabrazhynetskaya A
Biologicals; 2019 May; 59():56-61. PubMed ID: 30898479
[TBL] [Abstract][Full Text] [Related]
17. Rabies virus glycoprotein serology ELISA for measurement of neutralizing antibodies in sera of vaccinated human subjects.
Zhao R; Yu P; Shan Y; Thirumeni N; Li M; Lv Y; Li J; Ren W; Huang L; Wei J; Sun Y; Zhu W; Sun L
Vaccine; 2019 Sep; 37(41):6060-6067. PubMed ID: 31471146
[TBL] [Abstract][Full Text] [Related]
18. A thermostable messenger RNA based vaccine against rabies.
Stitz L; Vogel A; Schnee M; Voss D; Rauch S; Mutzke T; Ketterer T; Kramps T; Petsch B
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006108. PubMed ID: 29216187
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
[TBL] [Abstract][Full Text] [Related]
20. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
